Jersey GP Surgery introduces Skin Analytics’ AI as a medical device DERM to offer patients earlier diagnosis and avoid unnecessary referrals to specialist services. First
Human Bytes has entered a strategic partnership with UK based Skin Analytics to bring the world’s only autonomous AI for assessment and triage of suspected
Skin Analytics has partnered with UK-based private medical insurance provider Freedom Health to support the launch of Freedom Dermatology, available to all Freedom Health members
As seen at Affidea.com Affidea, a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including oncology, has entered a strategic partnership with Skin
Residents in Barking & Dagenham now have faster, more accurate access to skin cancer checks thanks to a new partnership between Skin Analytics and Together First CIC, the borough’s GP Federation.
Bridgewater Community Healthcare NHS Foundation Trust and Warrington and Halton Teaching Hospitals NHS Foundation Trust are using the latest in AI technology to provide patients with a swifter diagnosis of skin cancer.
With 19,000 patients supported, we look back on 5 incredible years since Bupa launched a home-based service for skin cancer assessments with Skin Analytics.
Register for this HSJ webinar to hear how primary and secondary care organisations across Suffolk and North East Essex ICB worked in partnership to deploy DERM.
Following the implementation of DERM, Kingston and Richmond NHS Foundation Trust have been shortlisted for two HTN awards – Best use of AI for diagnosis, treatment and patient care & AI Solution of the Year.
Bolton NHS Foundation Trust are the next Trust in Greater Manchester to deploy DERM into their urgent suspected skin cancer pathway.
The Times reports on Chelsea and Westminster Hospital NHS Foundation Trust deploying DERM autonomously, marking a new era for cancer care.
Our longstanding NHS partner, Chelsea and Westminster Hospital NHS Foundation Trust, are now deploying DERM to identify and discharge patients with benign lesions, without validation from their dermatology team.
We’re delighted to be finalists for FIVE 2025 HSJ Partnership Awards alongside our NHS partners.
West Middlesex University Hospital, part of Chelsea and Westminster Hospital NHS Foundation Trust, are set to deliver a post-referral service for suspected skin cancer using AI Teledermatology.
Session recording now available to watch! At this year’s NHS Providers Conference, NHS University Hospitals of Liverpool Group shared value seen, learnings and future plans following the implementation of DERM.
Last night we joined our partners, NHS Suffolk and North East Essex Integrated Care Board and Chelsea and Westminster Hospital NHS Foundation Trust to celebrate their nominations at the HSJ Awards 2024.
Another NHS partnership! But this time with HMR in primary care! HMR will leverage AI-driven teledermatology to discharge patients with benign lesions earlier in the
The Northern Cancer Alliance launches an AI-driven post-referral service for suspected skin cancer with Skin Analytics in Stockport, Bury and Salford.
Skin Analytics and University Hospitals Dorset NHS Foundation Trust share how the Trust implemented DERM to address rising urgent suspected skin cancer referrals, finite dermatology capacity and a patient population with high incidence rates of skin cancer.
With a 300% increase in urgent suspected skin cancer referrals since 2010 and 45-50 patients seen per day at the Skin Cancer Centre in Amersham Hospital, Buckinghamshire Healthcare NHS Trust implements DERM to address their increasing dermatology demand.
Chelsea and Westminster Hospital NHS Foundation Trust (CWFT) and NHS Suffolk and North East Essex Integrated Care Board (SNEE) have been shortlisted for the HSJ Awards 2024, recognising an outstanding contribution to healthcare and securing a place at the prestigious awards ceremony later this year.
Last month, Alastair Fee, reporter at the BBC, visited UHD’s dermatology department at Christchurch to see how our AI as a medical device is being used to drive quicker access to skin cancer diagnosis for patients in the locality and reduce waiting times.
Tameside and Glossop Integrated Care NHS Foundation Trust are a General Manchester based trust who are opening their doors again to urgent suspected skin cancer referrals – only this time the post-referral service will use AI Teledermatology.
Manchester University NHS Foundation Trust launches a post-referral service for suspected skin cancer with Skin Analytics.
People passionate about building a world where no one dies from skin cancer, all in one room at the Skin Analytics Customer Conference!
By leveraging our AI medical device, DERM, within UHD’s post-referral pathway, we will look to address the gap between demand and capacity so the Trust’s dermatologists can spend precious time on patients who need them most.
With extremely limited dermatology capacity resulting in all Trust resources consumed by efforts to meet FDS targets, this AI powered pathway will remove the need to see patients with benign lesions face-to-face and reserve Dorset County Hospital’s dermatology capacity for patients with skin cancer.
Rishi Sunak and Skin Analytics were invited to a meet and greet at Woking Community Hospital to see the work being delivered at Woking Community Centre’s Diagnostic Hub.
LUHFT are one of the additional nine NHS trusts awarded funding to pilot DERM, and their patients in the Sefton area will be first out of approximately 45,000 patients to benefit from our technology by the summer – when skin cancer referrals are at their highest.
An additional nine NHS trusts have been funded to pilot Skin Analytics’ AI medical device to detect cancerous skin lesions, with around 45,000 patients benefiting from this groundbreaking technology by the summer when skin cancer referrals are at their highest.
